Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Will Nvidia Beat Q1 Expectations? Analyst Says Likely, Backed By AI and Gaming GPU Ramp Up

Rosenblatt analyst Hans Mosesmann reiterates Nvidia Corp (NASDAQ:NVDA) with a Buy and a $320 price target. The analyst expects Nvidia to meet…
byAnusuya Lahiri
May 11, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • Rosenblatt analyst Hans Mosesmann reiterates Nvidia Corp (NASDAQ:NVDA) with a Buy and a $320 price target.
  • The analyst expects Nvidia to meet or slightly beat April quarter and July quarter outlook expectations on data center Hopper H100 ramp, solid Gaming trends (Ada Lovelace), and stable networking (NICs, switching, and DPUs).
  • He sees Nvidia driving the biggest technology inflection the world may have seen in transformational AI everywhere and in everything. 
  • Jensen’s AI vision is openly playing out coincident with what appears to be Intel Corp’s (NASDAQ:INTC) structural secular decline, signaling a changing of the guard in silicon valley for generational semiconductor global leadership.
  • The stock is up 99% YTD.
  • Price Action: NVDA shares traded lower by 0.95% at $286.07 on the last check Thursday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

AstraZeneca And Merck Announced Results From The Final Analysis Of Overall Survival From Phase 3 Propel Trial Of Lynparza Plus Abiraterone And Prednisone Or Prednisolone (Abi/Pred), Compared To Placebo Plus Abi/Pred. Did Not Reach Statistical Significa…

By Benzinga Newsdesk
February 16, 11:04 AM
Median OS was 42.1 months for the LYNPARZA plus abi/pred arm versus 34.7 months for the placebo plus abi/pred arm, representing a 7.4-month absolute difference in median OS versus a standard of care

AZN